Integrated BioPharma, Inc. (INBP)
OTCMKTS
· Delayed Price · Currency is USD
0.300
+0.040 (15.38%)
Feb 14, 2025, 4:00 PM EST
Integrated BioPharma Ratios and Metrics
Market cap in millions USD. Fiscal year is July - June.
Millions USD. Fiscal year is Jul - Jun.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Feb '25 Feb 14, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2019 - 2015 |
| Market Capitalization | 10 | 6 | 10 | 15 | 33 | 13 | Upgrade
|
| Market Cap Growth | 35.38% | -36.28% | -33.74% | -54.33% | 146.41% | 95.65% | Upgrade
|
| Enterprise Value | 9 | 6 | 10 | 19 | 41 | 22 | Upgrade
|
| Last Close Price | 0.33 | 0.21 | 0.33 | 0.50 | 1.10 | 0.45 | Upgrade
|
| PE Ratio | 10.56 | 56.44 | - | 3.90 | 4.09 | 3.24 | Upgrade
|
| PS Ratio | 0.19 | 0.13 | 0.20 | 0.27 | 0.52 | 0.25 | Upgrade
|
| PB Ratio | 0.50 | 0.33 | 0.53 | 0.81 | 2.29 | 2.19 | Upgrade
|
| P/TBV Ratio | 0.51 | 0.33 | 0.53 | 0.81 | 2.29 | 2.19 | Upgrade
|
| P/FCF Ratio | 5.67 | 16.21 | 8.89 | 4.15 | 11.90 | 11.83 | Upgrade
|
| P/OCF Ratio | 4.32 | 6.70 | 8.05 | 3.66 | 10.75 | 9.94 | Upgrade
|
| EV/Sales Ratio | 0.17 | 0.13 | 0.20 | 0.35 | 0.64 | 0.42 | Upgrade
|
| EV/EBITDA Ratio | 3.12 | 11.12 | 21.85 | 6.31 | 6.68 | 6.14 | Upgrade
|
| EV/EBIT Ratio | 6.02 | 25.26 | 85.75 | 7.08 | 7.07 | 6.72 | Upgrade
|
| EV/FCF Ratio | 5.02 | 16.26 | 9.22 | 5.39 | 14.84 | 19.48 | Upgrade
|
| Debt / Equity Ratio | 0.07 | 0.09 | 0.14 | 0.11 | 0.42 | 1.84 | Upgrade
|
| Debt / EBITDA Ratio | 0.47 | 1.14 | 1.91 | 0.55 | 0.84 | 2.41 | Upgrade
|
| Debt / FCF Ratio | 0.76 | 4.61 | 2.39 | 0.57 | 2.18 | 9.90 | Upgrade
|
| Asset Turnover | 2.03 | 1.95 | 2.00 | 2.22 | 2.63 | 2.47 | Upgrade
|
| Inventory Turnover | 4.05 | 4.32 | 4.37 | 4.37 | 4.96 | 4.87 | Upgrade
|
| Quick Ratio | 1.20 | 1.04 | 1.21 | 0.99 | 0.66 | 0.46 | Upgrade
|
| Current Ratio | 3.26 | 2.92 | 3.39 | 3.16 | 1.95 | 1.26 | Upgrade
|
| Return on Equity (ROE) | 4.85% | 0.59% | -0.18% | 23.32% | 78.55% | 103.22% | Upgrade
|
| Return on Assets (ROA) | 3.52% | 0.61% | 0.30% | 6.77% | 14.94% | 9.53% | Upgrade
|
| Return on Capital (ROIC) | 4.32% | 0.74% | 0.36% | 8.38% | 19.26% | 12.73% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.21% | 1.25% | 0.58% | 13.73% | 35.69% | 33.10% | Upgrade
|
| Earnings Yield | 9.41% | 1.77% | -0.34% | 25.63% | 24.44% | 30.88% | Upgrade
|
| FCF Yield | 17.63% | 6.17% | 11.25% | 24.08% | 8.40% | 8.46% | Upgrade
|
| Buyback Yield / Dilution | -4.24% | -3.09% | 7.34% | -0.65% | -3.07% | -5.31% | Upgrade
|
| Total Shareholder Return | -4.24% | -3.09% | 7.34% | -0.65% | -3.07% | -5.31% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.